Klaus Ley
克劳斯·雷
MD
Professor & Director, Division of Inflammation Biology教授兼炎症生物学部门主任
👥Biography 个人简介
Leading authority on monocyte and macrophage differentiation at the La Jolla Institute for Immunology. Ley defined the Ly6C-high and Ly6C-low monocyte subsets and identified NR4A1 and KLF4 transcription factors controlling macrophage fate decisions underpinning TAM recruitment in tumors.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Monocyte Subset Trafficking & Differentiation
Defined the Ly6C-high and Ly6C-low monocyte subsets and their distinct trafficking programs, establishing the molecular basis for monocyte-to-macrophage differentiation in inflamed tissues including the tumor microenvironment.
Transcriptional Control of Myeloid Identity
Identified NR4A1 and KLF4 as key transcription factors governing monocyte patrolling behavior and macrophage polarization, providing molecular targets for TME reprogramming strategies.
Representative Works 代表性著作
Monocyte and macrophage heterogeneity
Nature Reviews Immunology (2011)
Definitive review establishing the functional dichotomy of monocyte subsets and the transcriptional programs controlling their fate in health, inflammation, and cancer.
Nr4a1-Dependent Ly6Clow Monocytes Monitor Endothelial Cells and Orchestrate Their Disposal
Science (2013)
Showed NR4A1 transcription factor is required for the patrolling Ly6C-low monocyte subset, linking nuclear receptor signaling to tissue surveillance and TME seeding.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Faisal Mahmood
Brigham and Women's Hospital; Harvard Medical School
Kun-Hsing Yu
Harvard Medical School; Brigham and Women's Hospital
Ziad Obermeyer
University of California, Berkeley; UC San Francisco
Andrew H. Beck
PathAI; Harvard Medical School (formerly)
关注 克劳斯·雷 的研究动态
Follow Klaus Ley's research updates
留下邮箱,当我们发布与 Klaus Ley(La Jolla Institute for Immunology)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment